Platinum ineligibility in squamous cell carcinoma of the head and neck: consensus from Central America and the Caribbean

被引：1

作者：

Alvarado-Munoz, Juan F. ^{[1
]}

Falco, Agustin ^{[2
]}

Morales, Agatha R. ^{[1
]}

Sanchez, Noe C. ^{[3
]}

Reynoso, Giovanni ^{[3
]}

Barillas, Allan ^{[3
]}

Moreno, Jairo ^{[4
]}

Lopez, Kreilin ^{[5
]}

Prestol, Rogelio ^{[5
]}

Cabreja, Angela ^{[6
]}

Nunez, Cesar ^{[6
]}

机构：

[1] Roosevelt Hosp, Guatemala City, Guatemala

[2] Alexander Fleming Inst Oncol, Buenos Aires, DF, Argentina

[3] Guatemalan Social Secur Inst, Guatemala City, Guatemala

[4] Natl Police Hosp, Managua, Nicaragua

[5] Heriberto Pieter Canc Inst, Santo Domingo, Dominican Rep

[6] Reg Oncol Inst Cibao, Santiago Los Caballeros, Dominican Rep

来源：

FUTURE ONCOLOGY | 2021年 / 17卷 / 15期

关键词：

cetuximab; Cisplatin; head and neck cancer; platinum toxicity; LOCALLY ADVANCED HEAD; CISPLATIN-INDUCED NEPHROTOXICITY; QUALITY-OF-LIFE; WEIGHT-LOSS; ELDERLY-PATIENTS; AIR-POLLUTION; HEARING-LOSS; LUNG-CANCER; RADIOTHERAPY; CONCURRENT;

D O I：

10.2217/fon-2020-0931

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The high incidence of head and neck cancer in Central America and the Caribbean, together with limitations in the healthcare system for patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) in this region necessitate a consensus of opinion based on a review of the literature on therapy with cisplatin plus radiation. Such an approach will ensure appropriate selection of patients who can benefit from therapy and reduce the incidence of related adverse events. Therefore, we recorded the opinion of experts in the region in order to identify needs and challenges in the treatment of LA SCCHN.

引用

页码：1963 / 1971

页数：9

共 50 条

[31] Systemic Treatment for Squamous Cell Carcinoma of the Head and Neck
Shetty, Aditya V.
Wong, Deborah J.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (04) : 775 - +
[32] Management of oligometastatic head and neck squamous cell carcinoma: A systematic review
Lehyanti, Jihane
Even, Caroline
Fessart, Etienne
Wagner-Ballon, Cyriaque
Moreira, Aurelie
Houessinon, Aline
ORAL ONCOLOGY, 2024, 159
[33] Examining adjuvant radiation dose in head and neck squamous cell carcinoma
Avkshtol, Vladimir
Handorf, Elizabeth A.
Ridge, John A.
Leachman, Brooke K.
Liu, Jeffrey C.
Bauman, Jessica
Galloway, Thomas J.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (07): : 2133 - 2142
[34] EGFR Mutations in Head and Neck Squamous Cell Carcinoma
Nair, Sindhu
Bonner, James A.
Bredel, Markus
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[35] Molecular profiling of head and neck squamous cell carcinoma
Feldman, Rebecca
Gatalica, Zoran
Knezetic, Joseph
Reddy, Sandeep
Nathan, Cherie-Ann
Javadi, Nader
Teknos, Theodoros
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1625 - E1638
[36] The promise of immunotherapy in head and neck squamous cell carcinoma
Economopoulou, P.
Agelaki, S.
Perisanidis, C.
Giotakis, E. I.
Psyrri, A.
ANNALS OF ONCOLOGY, 2016, 27 (09) : 1675 - 1685
[37] Spotlight on Cetuximab in Squamous Cell Carcinoma of the Head and Neck
Frampton, James E.
BIODRUGS, 2011, 25 (02) : 129 - 133
[38] The overall treatment of head and neck squamous cell carcinoma (SCC) in 2015
Guigay, J.
ONCOLOGIE, 2015, 17 (5-6) : 215 - 219
[39] Neoadjuvant immunotherapy for head and neck squamous cell carcinoma
Kuerten, Cornelius H. L.
Ferris, Robert L.
LARYNGO-RHINO-OTOLOGIE, 2024, 103 : S167 - S187
[40] Essential news of current guidelines: head and neck squamous cell carcinoma
Fuereder, Thorsten
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (04) : 278 - 281

← 1 2 3 4 5 →